Substantial Shareholding
20 April 2006 - 1:15AM
UK Regulatory
RNS Number:6865B
Bespak PLC
19 April 2006
For immediate release 19 April 2006
Bespak plc
('the Company')
Substantial Shareholding
Bespak plc (LSE: BPK), a leader in specialty medical devices, reports, further
to a letter received 19 April 2006, that the AEGON UK plc Group of Companies
and its subsidiaries sold 50,000 Ordinary Shares of 10 pence in the Company or
0.21% of their issued class.
Following this transaction, AEGON UK plc and its subsidiaries now own 818,522
Ordinary Shares of 10 pence or 2.92% of their issued class as follows:
Subsidiary Number of shares
Chase Nominees Limited 818,522
ENDS
For further information please call:
Bespak plc
Mark Throdahl - Chief Executive +44 (0) 20 1908 552 600
Martin Hopcroft - Group Finance Director
Buchanan Communications +44 (0) 20 7466 5000
Tim Thompson / Mary-Jane Johnson / Elly Williamson
Notes for Editors:
About Bespak plc
Bespak, a leader in specialty medical devices, develops delivery systems for the
pharmaceutical industry and disposable airway management products for critical
care settings. Bespak's product range includes metered dose and dry powder
inhalers, actuators, inflation valves, disposable face masks, breathing circuits
and laryngeal tubes. The group, which has facilities in King's Lynn and Milton
Keynes in the UK and Indianapolis and Kent, Ohio, in the US, is quoted on the
Official List of the London Stock Exchange (LSE: BPK). For more information,
please visit www.bespak.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLILFLESFIALIR
Bespak (LSE:BPK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bespak (LSE:BPK)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Bespak (London Stock Exchange): 0 recent articles
More Bespak Plc News Articles